Le Lézard
Classified in: Covid-19 virus
Subjects: MAV, CFG

Media Advisory: Virtual COVID-19 Resilience Announcement in Ottawa


OTTAWA, ON, May 7, 2021 /CNW/ - Members of the media are invited to attend an important virtual infrastructure event with the Honourable Catherine McKenna, Minister of Communities and Infrastructure; the Honourable Laurie Scott, Ontario's Minister of Infrastructure; and His Worship Jim Watson, Mayor of the City of Ottawa.

Date:

Monday, May 10, 2021



Time:  

10:00 a.m. EDT



Zoom event: 

To attend the virtual event, members of the media are asked to register by sending an email to [email protected]. Once you are online, please keep your phone muted.



Livestream: 

Members of the public are invited to view the live announcement on the Infrastructure Canada's Facebook page: https://www.facebook.com/InfrastructureCanadaENG/live

Follow us on Twitter, Facebook and Instagram 

Web: Infrastructure Canada

SOURCE Infrastructure Canada


These press releases may also interest you

at 07:05
LiveWire Group, Inc. Reports 2024 First Quarter Financial Results
LiveWire Group, Inc. ("LiveWire" or the "Company") today reported first quarter 2024 results. "We are pleased with the successful launch of the S2 Mulholland, and with three bikes in market, we are proud that LiveWire is now the #1 on-road...

at 07:05
Newmont Reports First Quarter 2024 Results
Newmont Corporation (Newmont or the Company) today announced first quarter 2024 results and declared a first quarter dividend of $0.25 per share. "Newmont delivered a strong first quarter operational performance, producing 2.2 million gold...

at 07:05
Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it published an article in the Experimental and Therapeutic Medicine...

at 07:03
Deloitte's 14th Annual Pharmaceutical Innovation Report: Pharma R&D Return on Investment Rebounds After Record Low
Key takeaways Projected return on investment in pharma research and development (R&D) in 2023 has risen to 4.1%, climbing back from 2022's record low of 1.2%.The leading 20 global pharmaceutical companies collectively spent $145 billion on R&D in...

at 07:00
Harley-Davidson Delivers First Quarter Financial Results
Harley-Davidson, Inc. ("Harley-Davidson," "HDI," or the "Company")  today reported first quarter 2024 results. "Harley-Davidson delivered a good start to the year with a six percent retail growth in North America, our largest and most important...

at 07:00
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Moderna, Inc. today announced that the Company will present data from its respiratory portfolio, including vaccines and vaccine candidates against COVID-19 (mRNA-1273, mRNA-1283), influenza (mRNA-1010, mRNA-1011/1012), and respiratory syncytial...

More news about Covid-19 virus...


News published on and distributed by: